An Ohio woman has filed a product liability lawsuit alleging that she suffered kidney damage from Valturna, a hypertension drug that contains the active ingredient from the drug Tekturna.
Federal investigators are pursuing information from Novartis AG’s U.S. unit regarding the marketing of certain products, including the controversial blood pressure medication Tekturna.
A drug commonly used to treat high-blood pressure may pose a serious risk if used in combination with some other hypertension drugs, according to recent research.
According to a quarterly report issued on adverse drug events submitted to federal health officials, the number of complaints associated with prescription medications has jumped 90% over the last four…
The prominent consumer watch dog group Public Citizen is calling for the FDA to increase the strength of warnings provided with three classes of hypertension drugs, indicating that boxed warnings…
Federal health officials warn that the blood pressure drug Tekturna and similar medications should not be given to diabetics or patients with kidney problems in combination with drugs known as…
European drug regulators are calling for new kidney damage warnings for Tekturna and other drugs containing the active ingredient aliskiren.
Potential concerns about side effects of Tekturna, a blood pressure drug sold by Novartis, have surfaced after clinical trials were canceled due to a high number of strokes and kidney…
